he purpose of this report was to update the 2006 International League Against Epilepsy (ILAE) report and identify the level of evidence for long-term efficacy or effectiveness for antiepileptic drugs (AEDs) as initial monotherapy for patients with newly diagnosed or untreated epilepsy. All applicable articles from July 2005 until March 2012 were identified, evaluated, and combined with the previous ysis (Glauser et al., 2006) to provide a comprehensive update.
The prior ysis methodology was utilized with three modifications: (1) the detectable noninferiority boundary approach was dropped and both failed superiority studies and prespecified noninferiority studies were yzed using a noninferiority approach, (2) the definition of an adequate comparator was clarified and now includes an absolute minimum point estimate for efficacy/effectiveness, and (3) the relationship table between clinical trial ratings, level of evidence, and conclusions no longer includes a recommendation column to reinforce that this review of efficacy/evidence for specific seizure types does not imply treatment recommendations.
This evidence review contains one clarification: The commission has determined that class I superiority studies can be designed to detect up to a 20% absolute (rather than relative) difference in the point estimate of efficacy/effectiveness between study treatment and comparator using an intent-to-treat ysis. Since July, 2005, three class I randomized controlled trials (RCT) and 11 class III RCTs he been published. The combined ysis (1940-2012) now includes a total of 64 RCTs (7 with class I evidence, 2 with class II evidence) and 11 meta-yses.
New efficacy/effectiveness findings include the following: levetiracetam and zonisamide he level A evidence in s with partial onset seizures and both ethosuximide and valproic acid he level A evidence in children with childhood absence epilepsy.
There are no major changes in the level of evidence for any other subgroup. Levetiracetam and zonisamide join carbamazepine and phenytoin with level A efficacy/effectiveness evidence as initial monotherapy for s with partial onset seizures. Although ethosuximide and valproic acid now he level A efficacy/effectiveness evidence as initial monotherapy for children with absence seizures, there continues to be an alarming lack of well designed, properly conducted epilepsy RCTs for patients with generalized seizures/epilepsies and in children in general.
These findings reinforce the need for multicenter, multinational efforts to design, conduct, and yze future clinically relevant adequately designed RCTs. When selecting a patient's AED, all relevant variables and not just efficacy and effectiveness should be considered.
查看信源接收者
下一页:异性恋癫痫的主要原因有哪些
- 2022-04-26吡仑帕奈辅助用药可增加部分发作型癫痫患者的症状
- 2022-04-21异性恋癫痫的主要原因有哪些
- 2022-04-202013年国际性抗癫痫联合会抗癫痫药使用指南
- 2022-04-04医生拒绝医生拒绝做妇科手术,这层膜真的那么重要吗?
- 2022-03-28私密┃月经结束了。内衣上这些棕色的东西是什么?
- 2022-03-21介绍白癜风预防方法
- 超声造影“揪出”隐藏在肝脏内的定时
- 病例报告:水浴 PUVA 治疗皮下环状肉芽肿
- 包皮切除术怎么样?
- 老年性炎是怎么回事?
- 女生痛经只会多喝热水?快速学习这些救命的方法!
- 什么是霉菌性阴炎?
- 福州一医院用嫩模照片宣传妇科被判赔偿3.2 万
- 医生拒绝医生拒绝做妇科手术,这层膜真的那么重要吗?
- 他们在对抗子宫腺肌病的路上走了太多弯路!
- FDA警告怀孕期间使用丙戊酸钠药物
- 非淋性尿道炎症状 非淋性尿道炎怎么办?
- BMJ:阿托伐他汀对ICU新冠肺炎重症患者预后的影响
- 北京妇产医院首都医科大学第九届妇科内镜技术手拉手培训班
- 私密┃月经结束了。内衣上这些棕色的东西是什么?
- 如何预防炎症 滥用抗生素小心得这种病
- 治疗类风湿性关节炎/膝骨关节炎的专家共识
- 健康饮食 男人必吃的皇帝菜其实是
- 20140115健康生活视频全集:丁健华谈到便秘的危害
- 介绍白癜风预防方法
- 2015第31届国际癫痫大会(IEC)
- 炎症症状 这样治疗炎症效果好
- 灼烧综合征的原因不容忽视治疗
- 白癜风的症状是什么?
- 红辣椒怎么腌好吃 孕妇吃辣椒的注意事项
- 厕所会对健康造成这样的伤害
- 三庚酸酯可治疗1型转运体缺陷综合征
- 什么样的枕头可以治疗颈椎病?
- 【百年协和讲堂】肿块?红热?溢液?酒窝征?…可能是乳腺癌!
- 水果虽难看也许更健康
- 脑机接口运用新突破!浙大团队研发脑“反导系统”抑制癫痫
- 睡觉时突然抽搐一下 产妇睡觉抽搐怎么办
- 最常见的出现异常癫痫的病因是哪些
- 女性癫痫的征状是什么呢
- 癫痫病的就有症状是什么样的
- 无意识百科:解读“幼稚病”
- 小儿癫痫的最初症状 癫痫的原因
- 西兰花的做法大全 猪肉西兰花
- 癫痫病发病似乎是怎么回事
- AI个体化癫痫放射治疗管理新时代丨Airdoc莫纳什研究中心最新论文
- PM2.5危害巨大 对付室内PM2.5专家有妙招